Med Student Medical News about Diabetic Foot; Off Loading Devices

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Diabetic Foot: Off Loading Devices
Middle East Journal of Family Medicine, 07/01/09

Ahmed AA - It is estimated that approximately 15% of all people with diabetes will be affected by a foot ulcer during their lifetime. Foot problems are very expensive, common and life threatening. In developed countries, up to 5% of people with diabetes have foot problems. In developing countries diabetic foot lesions may face up to 40%. The key to successful pressure reduction in diabetics with foot problems lies more in patient adherence than in prescribed offloading devices. Combining an effective, easy to use offloading device that ensures patient compliance will have a high success rate on reducing the pressure and healing rate.

Exclusive Author Commentary
Almoutaz Alkhier Ahmed, 07/05/09

Due to the rising of the prevalence of diabetes world wide and the improper methods of care, the prevalence of complications also raised. A diabetic foot problem is among those complications started to rise and began to throw heavy loads upon the health resources. Offloading is a cornerstone in the management of diabetic foot problems. Good selection of the offloading device may help in healing ulcers or saving limb but bad selection may add more hazards to patient(s) with certain foot problem(s). In my review about offloading devices, I went through different types of offloading devices showing their pros and cons, so health provider(s) can choose the appropriate device(s) for their patient(s). Dr.Almoutaz Alkhier Ahmed, IIWCC Saudi Arabia, Gurayat North, Diabetes Center

<< Previous
Inflammatory myofibroblastic tumor of the liver: A case report

Next >>
Gene- and Viral-Based Therapies for Brain Tumors